» Articles » PMID: 30893880

Antibiotic Resistance in Pacific Island Countries and Territories: A Systematic Scoping Review

Overview
Specialty Pharmacology
Date 2019 Mar 22
PMID 30893880
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Several studies have investigated antimicrobial resistance in low- and middle-income countries, but to date little attention has been paid to the Pacific Islands Countries and Territories (PICTs). This study aims to review the literature on antibiotic resistance (ABR) in healthcare settings in PICTs to inform further research and future policy development for the region. Following the PRISMA-ScR checklist health databases and grey literature sources were searched. Three reviewers independently screened the literature for inclusion, data was extracted using a charting tool and the results were described and synthesised. Sixty-five studies about ABR in PICTs were identified and these are primarily about New Caledonia, Fiji and Papua New Guinea. Ten PICTs contributed the remaining 21 studies and nine PICTs were not represented. The predominant gram-positive pathogen reported was community-acquired methicillin resistant and the rates of resistance ranged widely (>50% to <20%). Resistance reported in gram-negative pathogens was mainly associated with healthcare-associated infections (HCAIs). Extended spectrum beta-lactamase (ESBL) producing isolates were reported in New Caledonia (3.4%) and Fiji (22%) and carbapenem resistant isolates in the French Territories (24.8%). ABR is a problem in the PICTs, but the epidemiology requires further characterisation. Action on strengthening surveillance in PICTs needs to be prioritised so strategies to contain ABR can be fully realised.

Citing Articles

Waterborne polyurethane nanoparticles incorporating linoleic acid as a potential strategy for controlling antibiotic resistance spread in the mammalian intestine.

Li G, Han L, Xia L, Gao A, Li Z, Zhou S Mater Today Bio. 2024; 28:101181.

PMID: 39221217 PMC: 11364912. DOI: 10.1016/j.mtbio.2024.101181.


The changing epidemiology of antimicrobial resistance in Fiji: a descriptive analysis of antimicrobial susceptibility and trends of endemic and emerging pathogens, 2019-2022.

Getahun Strobel A, Prasad P, Lane C, Naidu R, Autar S, Young-Sharma T Lancet Reg Health West Pac. 2024; 45:101036.

PMID: 38516290 PMC: 10955629. DOI: 10.1016/j.lanwpc.2024.101036.


Antimicrobial Resistance in Papua New Guinea: A Narrative Scoping Review.

Page B, Adiunegiya S Antibiotics (Basel). 2023; 12(12).

PMID: 38136713 PMC: 10741211. DOI: 10.3390/antibiotics12121679.


The Impact of COVID-19 on Knowledge, Beliefs, and Practices of Ni-Vanuatu Health Workers Regarding Antibiotic Prescribing and Antibiotic Resistance, 2018 and 2022: A Mixed Methods Study.

Foxlee N, Taleo S, Mathias A, Townell N, McIver L, Lau C Trop Med Infect Dis. 2023; 8(10).

PMID: 37888605 PMC: 10611053. DOI: 10.3390/tropicalmed8100477.


Ertapenem Supplemented Selective Media as a New Strategy to Distinguish β-Lactam-Resistant Enterobacterales: Application to Clinical and Wastewater Samples.

Bourles A, Kainiu M, Ukeiwe D, Brunet N, Despaux C, Biron A Antibiotics (Basel). 2023; 12(2).

PMID: 36830303 PMC: 9952050. DOI: 10.3390/antibiotics12020392.


References
1.
Duke T, Michael A . Increase in sepsis due to multi-resistant enteric gram-negative bacilli in Papua New Guinea. Lancet. 1999; 353(9171):2210-1. DOI: 10.1016/S0140-6736(99)02389-2. View

2.
Duke T . Antibiotic-resistant bacterial sepsis in Papua New Guinea. P N G Med J. 2001; 43(1-2):82-90. View

3.
Gosbell I, Mercer J, Neville S, Crone S, Chant K, Jalaludin B . Non-multiresistant and multiresistant methicillin-resistant Staphylococcus aureus in community-acquired infections. Med J Aust. 2001; 174(12):627-30. DOI: 10.5694/j.1326-5377.2001.tb143470.x. View

4.
Duke T, Michael A, Mokela D, Wal T, Reeder J . Chloramphenicol or ceftriaxone, or both, as treatment for meningitis in developing countries?. Arch Dis Child. 2003; 88(6):536-9. PMC: 1763115. DOI: 10.1136/adc.88.6.536. View

5.
Trevett A, Sengupta S . Gentamicin resistance in fatal Klebsiella septicaemia. P N G Med J. 1992; 35(3):202-4. View